HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
KCNK18
potassium two pore domain channel subfamily K member 18
Chromosome 10 · 10q25.3
NCBI Gene: 338567Ensembl: ENSG00000186795.2HGNC: HGNC:19439UniProt: Q7Z418
34PubMed Papers
21Diseases
5Drugs
3Pathogenic Variants
FUNCTIONAL ROLE
Ion ChannelTransporter
CLINICAL
FDA Approved TargetOMIM Disease Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
potassium ion export across plasma membraneplasma membraneoutward rectifier potassium channel activitypotassium ion transportmigraine disorderacute respiratory distress syndromeCOVID-19coronary artery disease
✦AI Summary

KCNK18 encodes TRESK, a two-pore domain potassium channel that conducts voltage-dependent outward and inward rectifying currents at depolarized and hyperpolarized membrane potentials, respectively 123456. The channel forms homo- and heterodimers with distinct regulatory properties. In trigeminal sensory neurons, KCNK18 heterodimers stabilize resting membrane potential and regulate action potential threshold and spike frequency, thereby inhibiting neuronal firing and neurogenic inflammation. In thymocytes, KCNK18 conducts K+ currents upon T cell receptor signaling, promoting sustained Ca2+ influx and NF-κB activation to facilitate regulatory T cell differentiation 7. KCNK18 variants are implicated in migraine pathogenesis, with mutations identified in both familial hemiplegic migraine and common migraine forms 891011. An Italian cohort study identified multiple genetic variants (R10G, C110R, S231P, F372L) in 5.1% of migraine with aura and 7.1% of migraine without aura patients; in silico analysis suggested some variants have potentially damaging effects on channel function 12. Zebrafish modeling demonstrated that K2P18.1 channels stabilize resting membrane potential through K+-selective background currents and share regulatory properties with the human ortholog 13. Recent evidence expands KCNK18's clinical relevance beyond migraine to neurodevelopmental disorders, with biallelic variants associated with intellectual disability and autism spectrum disorder 14. KCNK18 variants were also detected in both painful and painless diabetic neuropathy patients, though their causal role remains unclear 15.

Sources cited
1
In thymocytes, KCNK18 conducts K+ currents upon T cell receptor signaling, promoting sustained Ca2+ influx and NF-κB activation to facilitate regulatory T cell differentiation .
PMID: 34702947
2
An Italian cohort study identified multiple genetic variants (R10G, C110R, S231P, F372L) in 5.1% of migraine with aura and 7.1% of migraine without aura patients; in silico analysis suggested some variants have potentially damaging effects on channel function .
PMID: 25324165
3
Zebrafish modeling demonstrated that K2P18.1 channels stabilize resting membrane potential through K+-selective background currents and share regulatory properties with the human ortholog .
PMID: 24311292
4
Recent evidence expands KCNK18's clinical relevance beyond migraine to neurodevelopmental disorders, with biallelic variants associated with intellectual disability and autism spectrum disorder .
PMID: 34199759
5
KCNK18 variants were also detected in both painful and painless diabetic neuropathy patients, though their causal role remains unclear .
PMID: 35806193
Disease Associationsⓘ21
migraine disorderOpen Targets
0.42Moderate
acute respiratory distress syndromeOpen Targets
0.35Weak
COVID-19Open Targets
0.35Weak
coronary artery diseaseOpen Targets
0.33Weak
respiratory failureOpen Targets
0.32Weak
cancerOpen Targets
0.31Weak
ischemia reperfusion injuryOpen Targets
0.27Weak
brain aneurysmOpen Targets
0.26Weak
cerebral arterial diseaseOpen Targets
0.26Weak
esophageal cancerOpen Targets
0.26Weak
fluoride poisoningOpen Targets
0.26Weak
severe acute respiratory syndromeOpen Targets
0.26Weak
alcohol drinkingOpen Targets
0.24Weak
morbid obesityOpen Targets
0.18Weak
Parkinson diseaseOpen Targets
0.12Weak
parkinsonian disorderOpen Targets
0.12Weak
vascular parkinsonismOpen Targets
0.12Weak
congenital heart diseaseOpen Targets
0.08Suggestive
drug dependenceOpen Targets
0.07Suggestive
subarachnoid hemorrhageOpen Targets
0.07Suggestive
Migraine with or without aura 13UniProt
Pathogenic Variants3
NM_181840.1(KCNK18):c.755C>T (p.Ser252Leu)Likely pathogenic
not provided
★☆☆☆2025→ Residue 252
NM_181840.1(KCNK18):c.487T>G (p.Tyr163Asp)Pathogenic
Migraine, with or without aura, susceptibility to, 13
★☆☆☆2022→ Residue 163
NM_181840.1(KCNK18):c.499C>T (p.Arg167Ter)Pathogenic
KCNK18-related neurodevelopmental disorder
★☆☆☆→ Residue 167
View on ClinVar ↗
Drug Targets5
DESFLURANEApproved
Potassium channel subfamily K member 10 opener
ENFLURANEApproved
Potassium channel subfamily K member 10 opener
HALOTHANEApproved
Potassium channel subfamily K member 10 opener
ISOFLURANEApproved
Potassium channel subfamily K member 2 opener
SEVOFLURANEApproved
Glycine receptor (alpha-1/beta) positive modulator
Related Genes
KCNK4Protein interaction88%KRT76Protein interaction88%KCNK13Protein interaction88%KCNK12Protein interaction88%KCNK1Protein interaction81%KCNK3Protein interaction81%
Tissue Expression6 tissues
Lung
0%
Bone Marrow
0%
Ovary
0%
Heart
0%
Liver
0%
Brain
0%
Gene Interaction Network
Click a node to explore
KCNK18KCNK4KRT76KCNK13KCNK12KCNK1KCNK3
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q7Z418
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.11LoF Tolerant
pLIⓘ
0.02Tolerant
Observed/Expected LoF0.62 [0.36–1.11]
RankingsWhere KCNK18 stands among ~20K protein-coding genes
  • #11,174of 20,598
    Most Researched34
  • #327of 1,025
    FDA-Approved Drug Targets5
  • #4,102of 5,498
    Most Pathogenic Variants3
  • #11,437of 17,882
    Most Constrained (LOEUF)1.11
Genes detectedKCNK18
Sources retrieved10 papers
Response time—
📄 Sources
10â–¼
1
Peripheral Ion Channel Gene Screening in Painful- and Painless-Diabetic Neuropathy.
PMID: 35806193
Int J Mol Sci · 2022
1.00
2
Ion channelopathies and migraine pathogenesis.
PMID: 28389699
Mol Genet Genomics · 2017
0.90
3
Migraine: Genetic Variants and Clinical Phenotypes.
PMID: 30027842
Curr Med Chem · 2019
0.80
4
Migraine genetics: Part II.
PMID: 23919895
Headache · 2013
0.70
5
Molecular factors in migraine.
PMID: 27191890
Oncotarget · 2016
0.60